In this article, the focus will be restricted to the following non-invasive technologies: transcranial magnetic stimulation, or TMS; magnetic seizure therapy (MST); transcutaneous vagal nerve stimulation (t-VNS); and transcranial direct current stimulation (tDCS).
Read More
Most clinicians are familiar with the use of brain CT scans in an emergency situation. But what about other imaging modalities? How are they being employed to add to the understanding of mood disorders? And when might they be appropriate for general clinical use?
Read More
What is the current usage, popularity and techniques for electroconvulsive therapy (ECT)? Dr. Lisanby brings us up to date on the changes in the field of ECT.
Read More
Does marijuana affect cognitive function? There seems to be no shortage of opinions on this question, but no prospective, longitudinal study has ever been published. Until now, that is.
Read More
It seems that not a week goes by without another research paper drawing attention to the interface between immunology and psychiatry, or about biomarkers to predict response to psychotropic medications. A recent report from researchers at Emory University weighs in on both of these issues.
Read More
Dr. Aiken is the Editor in Chief of The Carlat Psychiatry Report; director of the Mood Treatment Center in North Carolina, where he maintains a private practice combining medication and therapy along with evidence-based complementary and alternative treatments; and Assistant Professor NYU Langone Department of Psychiatry. He has worked as a research assistant at the NIMH and a sub-investigator on clinical trials, and conducts research on a shoestring budget out of his private practice. Follow him on Twitter and find him on LinkedIn.
_-The-Breakthrough-Antipsychotic-That-Could-Change-Everything.jpg?1729528747 "KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg")
